FSLBX
Price
$167.23
Change
-$0.43 (-0.26%)
Updated
Jun 22 closing price
Net Assets
941.07M
RYFAX
Price
$91.43
Change
+$0.38 (+0.42%)
Updated
Jun 22 closing price
Net Assets
11.18M
Interact to see
Advertisement

FSLBX vs RYFAX

FSLBX vs RYFAX Comparison Chart in %
View a ticker or compare two or three
VS
FSLBX vs. RYFAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLBX is a Hold and RYFAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSLBX has more cash in the bank: 941M vs. RYFAX (11.2M). RYFAX pays higher dividends than FSLBX: RYFAX (1.43) vs FSLBX (0.72). FSLBX was incepted earlier than RYFAX: FSLBX (41 years) vs RYFAX (28 years). RYFAX (1.70) is less costly to investors than FSLBX (0.66). RYFAX is a more actively managed with annual turnover of: 280.00 vs. FSLBX (10.00). FSLBX has a lower initial minimum investment than RYFAX: FSLBX (0) vs RYFAX (2500). RYFAX annual gain was more profitable for investors over the last year : 6.83 vs. FSLBX (-7.77). FSLBX return over 5 years is better than : 51.40 vs. RYFAX (10.58).
FSLBXRYFAXFSLBX / RYFAX
Total Expense Ratio0.661.6540%
Annual Report Gross Expense Ratio0.661.7039%
Fund Existence41 years28 years-
Gain YTD-12.174-0.06618,487%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets941M11.2M8,402%
Annual Yield % from dividends0.721.4351%
Returns for 1 year-7.776.83-114%
Returns for 3 years58.9660.0498%
Returns for 5 years51.4010.58486%
Returns for 10 years227.63100.01228%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICEUX54.570.06
+0.11%
NYLI Epoch International Choice Class I
JEMSX56.18N/A
N/A
JPMorgan Emerging Markets Equity I
NMMGX11.10N/A
N/A
Northern Multi-Manager Glbl Real Estate
LOGWX46.71N/A
N/A
Lord Abbett Developing Growth F3
PXSCX21.27-0.03
-0.14%
Impax Small Cap Investor